Association between Industry Payments and Scholarly Impact among Academic Ophthalmologists

Abstract

Purpose The aim of this article is to examine the association between industry payments to ophthalmologists and scholarly impact.

Design Retrospective cross-sectional study.

Methods All ophthalmology faculty at United States accredited ophthalmology residency programs were included in this study. The main exposure was industry payments to ophthalmologists in 2016, as reported in the Centers for Medicare and Medicaid Services Open Payments Database. The primary outcome was Hirsch index (H-index), a measure of scholarly impact.

Results Among 1,653 academic ophthalmologists in our study, 1,225 (74%) received industry payments in 2016. We did not observe a difference between the mean H-index of ophthalmologists receiving any industry payments versus those not receiving any payments (p = 0.68). In analysis including only ophthalmologists who received industry payments, H-index differed significantly by payment amount: 12.6 for ophthalmologists receiving less than $100, 12.2 for those receiving $100 to 1,000, 18.8 for those receiving $1,000 to 10,000, 21.3 for those receiving $10,000 to 100,000, and 29.4 for those receiving greater than $100,000 (p < 0.001). Within each academic rank and gender, industry payments greater than $1,000 were associated with a higher H-index (p < 0.05).

Conclusions Although our analysis cannot prove causality, we observed a significant association between industry payments and scholarly impact among academic ophthalmologists, even after adjusting for gender, academic rank, and subspecialty. Prospective studies should further evaluate this relationship.

Keywords

conflict of interest - health policy - industry payments

• References

• 1 Department of Health and Human Services. Medicare, Medicaid, Children's Health Insurance Programs; Transparency Reports and Reporting of Physician Ownership or Investment Interests; Final Rule. 2013
• 2 Centers for Medicare & Medicaid Services. Open Payments. https://openpaymentsdata.cms.gov/ ; 2018. Accessed April 1, 2018
• 3 Ahmed R, Chow EK, Massie AB. , et al. Where the sun shines: industry's payments to transplant surgeons. Am J Transplant 2016; 16 (01) 292-300
• 4 Ahmed R, Lopez J, Bae S. , et al. The dawn of transparency: insights from the Physician Payment Sunshine Act in plastic surgery. Ann Plast Surg 2017; 78 (03) 315-323
• 5 Eloy JA, Kilic S, Yoo NG. , et al. Is industry funding associated with greater scholarly impact among academic neurosurgeons?. World Neurosurg 2017; 103: 517-525
• 6 Svider PF, Bobian M, Lin HS. , et al. Are industry financial ties associated with greater scholarly impact among academic otolaryngologists?. Laryngoscope 2017; 127 (01) 87-94
• 7 Kaestner V, Edmiston JB, Prasad V. The relation between publication rate and financial conflict of interest among physician authors of high-impact oncology publications: an observational study. CMAJ Open 2018; 6 (01) E57-E62
• 8 Taylor SC, Huecker JB, Gordon MO, Vollman DE, Apte RS. Physician-industry interactions and anti-vascular endothelial growth factor use among US ophthalmologists. JAMA Ophthalmol 2016; 134 (08) 897-903
• 9 Singh N, Chang JS, Rachitskaya AV. Open payments database: anti-vascular endothelial growth factor agent payments to ophthalmologists. Am J Ophthalmol 2017; 173: 91-97
• 10 Accreditation Council for Graduate Medical Education (ACGME). List of Programs by Specialty. Available at: https://apps.acgme.org/ads/Public ; 2018. Accessed February 1, 2018
• 11 American Academy of Ophthalmology. Find an Ophthalmologist. Available at: https://secure.aao.org/aao/find-ophthalmologist ; 2018. Accessed June 1, 2018
• 12 Centers for Medicare & Medicaid Services. Medicare, Medicaid, Children's Health Insurance Programs; Transparency Reports and Reporting of Physician Ownership or Investment Interests. 42 CFR Parts 402 and 403, RIN 0938–AR33, 2013
• 13 Centers for Medicare & Medicaid Services. Open Payments: Frequently Asked Questions (FAQS). Available at: https://www.cms.gov/OpenPayments/Downloads/open-payments-general-faq.pdf ; 2018. Accessed October 1, 2018
• 14 Scopus. Author Search. https://www.scopus.com ; 2018. Accessed April 1, 2018
• 15 Hirsch JE. An index to quantify an individual's scientific research output. Proc Natl Acad Sci U S A 2005; 102 (46) 16569-16572
• 16 Hirsch JE. Does the H index have predictive power?. Proc Natl Acad Sci U S A 2007; 104 (49) 19193-19198
• 17 Huang G, Fang CH, Lopez SA, Bhagat N, Langer PD, Eloy JA. Impact of fellowship training on research productivity in academic ophthalmology. J Surg Educ 2015; 72 (03) 410-417
• 18 Tringale KR, Hattangadi-Gluth JA. Types and distributions of biomedical industry payments to men and women physicians by specialty, 2015. JAMA Intern Med 2018; 178 (03) 421-423
• 19 Reddy AK, Bounds GW, Bakri SJ. , et al. Representation of women with industry ties in ophthalmology. JAMA Ophthalmol 2016; 134 (06) 636-643
• 20 Svider PF, Lopez SA, Husain Q, Bhagat N, Eloy JA, Langer PD. The association between scholarly impact and National Institutes of Health funding in ophthalmology. Ophthalmology 2014; 121 (01) 423-428
• 21 Fleischman W, Ross JS. Industry support of physician education in the USA. J Epidemiol Community Health 2017; 71 (03) 213-216
• 22 Moynihan RN, Cooke GPE, Doust JA, Bero L, Hill S, Glasziou PP. Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States. PLoS Med 2013; 10 (08) e1001500
• 23 Donohue JM, Morden NE, Gellad WF. , et al. Sources of regional variation in Medicare Part D drug spending. N Engl J Med 2012; 366 (06) 530-538
• 24 Austad KE, Avorn J, Kesselheim AS. Medical students' exposure to and attitudes about the pharmaceutical industry: a systematic review. PLoS Med 2011; 8 (05) e1001037
• 25 Goodman RL. Medical education and the pharmaceutical industry. Perspect Biol Med 2007; 50 (01) 32-39
• 26 Wang Y, Adelman RA. A study of interactions between pharmaceutical representatives and ophthalmology trainees. Am J Ophthalmol 2009; 148 (04) 619-622.e3
• 27 Stein GE, Kamler JJ, Chang JS. Ophthalmology patient perceptions of open payments information. JAMA Ophthalmol 2018; 136 (12) 1375-1381
• 28 Pharmaceutical Research and Manufacturers of America (PhRMA). Code on Interactions with Healthcare Professionals. Available at: https://www.phrma.org/codes-and-guidelines/code-on-interactions-with-health-care-professionals ; 2017. Accessed October 1, 2018
• 29 American Academy of Ophthalmology. Financial Disclosure, Conflict of Interest and Bias. Available at: https://www.aao.org/financial-disclosure-conflict-of-interest-and-bias ; 2016. Accessed October 1, 2018
• 30 Choudhri AF, Siddiqui A, Khan NR, Cohen HL. Understanding bibliometric parameters and analysis. Radiographics 2015; 35 (03) 736-746